INT MEDICAL (01501) Plans 16.13% Discounted Share Placement to Raise Approximately HK$884 Million Net

Stock News01-14

INT MEDICAL (01501) announced that on January 14, 2026 (after trading hours), the company entered into a placement agreement with joint placing agents. The company intends to issue 35.2 million placement shares through the joint placing agents at a price of HK$26 per share. This represents a discount of approximately 16.13% compared to the closing price of HK$31.00 per share on the Hong Kong Stock Exchange on January 14, 2026. Assuming all placement shares are fully subscribed and upon completion of the placement, the net proceeds are expected to be approximately HK$884 million. Approximately 56.54% of the net proceeds will be used to fund the company's ongoing expansion of its product portfolio through investments and potential acquisitions in the medical device industry; about 23.75% will be allocated to repay existing interest-bearing bank borrowings; and the remaining 19.71% will serve as the company's working capital and for other general corporate purposes, including employee costs and daily operational expenses.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment